Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · IEX Real-Time Price · USD
534.35
-6.27 (-1.16%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Thermo Fisher Revenue
Thermo Fisher had revenue of $42.49B in the twelve months ending March 30, 2024. Revenue in the quarter ending March 30, 2024 was $10.35B. In the year 2023, Thermo Fisher had annual revenue of $42.86B.
Revenue (ttm)
$42.49B
Revenue Growth
-3.00%
P/S Ratio
4.80
Revenue / Employee
$348,295
Employees
122,000
Market Cap
203.97B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 42.86B | -2.06B | -4.58% |
Dec 31, 2022 | 44.92B | 5.70B | 14.55% |
Dec 31, 2021 | 39.21B | 6.99B | 21.71% |
Dec 31, 2020 | 32.22B | 6.68B | 26.14% |
Dec 31, 2019 | 25.54B | 1.18B | 4.86% |
Dec 31, 2018 | 24.36B | 3.44B | 16.45% |
Dec 31, 2017 | 20.92B | 2.64B | 14.47% |
Dec 31, 2016 | 18.27B | 1.31B | 7.72% |
Dec 31, 2015 | 16.97B | 75.40M | 0.45% |
Dec 31, 2014 | 16.89B | 3.80B | 29.02% |
Dec 31, 2013 | 13.09B | 580.40M | 4.64% |
Dec 31, 2012 | 12.51B | 951.10M | 8.23% |
Dec 31, 2011 | 11.56B | 1.17B | 11.22% |
Dec 31, 2010 | 10.39B | 481.50M | 4.86% |
Dec 31, 2009 | 9.91B | -586.40M | -5.59% |
Dec 31, 2008 | 10.50B | 751.60M | 7.71% |
Dec 31, 2007 | 9.75B | 5.95B | 157.05% |
Dec 31, 2006 | 3.79B | 1.16B | 44.00% |
Dec 31, 2005 | 2.63B | 427.01M | 19.36% |
Dec 31, 2004 | 2.21B | 306.62M | 16.14% |
Dec 31, 2003 | 1.90B | 50.02M | 2.70% |
Dec 28, 2002 | 1.85B | -338.85M | -15.49% |
Dec 29, 2001 | 2.19B | -92.31M | -4.05% |
Dec 30, 2000 | 2.28B | -14.10M | -0.61% |
Jan 1, 2000 | 2.29B | 413.71M | 22.00% |
Jan 2, 1999 | 1.88B | -98.70M | -4.99% |
Jan 3, 1998 | 1.98B | -952.96M | -32.50% |
Dec 28, 1996 | 2.93B | 662.27M | 29.17% |
Dec 28, 1995 | 2.27B | 541.10M | 31.29% |
Dec 28, 1994 | 1.73B | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Johnson & Johnson | 81.80B |
Merck & Co. | 61.40B |
Pfizer | 55.09B |
AbbVie | 54.40B |
Novartis AG | 48.86B |
AstraZeneca | 47.61B |
Abbott Laboratories | 40.33B |
Amgen | 29.53B |
TMO News
- 3 days ago - $7.1 Billion Medical Refrigerators Market and Industry Insights, 2024-2030, Featuring Strategic Analysis of 42 Major Players, Including Godrej, Haier Biomedical, Thermo Fisher Scientific - GlobeNewsWire
- 6 days ago - Stock Of The Day: How To Predict Thermo Fisher Scientific Trend Reversals - Benzinga
- 10 days ago - Thermo Fisher Scientific Declares Quarterly Dividend - Business Wire
- 10 days ago - Thermo Fisher Scientific to Help Advance Myeloid Cancer Clinical Research and Treatment Utilizing Next Generation Sequencing Technology - Business Wire
- 11 days ago - Thermo Fisher Scientific Completes Acquisition of Olink, Announces Commencement of Subsequent Offering Period - Business Wire
- 12 days ago - Thermo Fisher Scientific Opens Its First Electron Microscopy Demo Center in Taiwan - Business Wire
- 13 days ago - UK's competition regulator clears $3.1 bln Thermo Fisher Scientific-Olink deal - Reuters
- 19 days ago - Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, July 24, 2024 - Business Wire